Bruce G. Allen Investments, LLC Halozyme Therapeutics, Inc. Transaction History
Bruce G. Allen Investments, LLC
- $123 Billion
- Q4 2024
A detailed history of Bruce G. Allen Investments, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 9 shares of HALO stock, worth $574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 9
-0.0%
Holding current value
$574
Previous $515,000
16.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
549Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.12 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$848 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$459 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$266 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$220 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.89B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...